pricing Archives -

Analysis casts doubt on increased use of telehealth after pandemic

https://pharmaphorum.com/news/analysis-casts-doubt-on-increased-use-of-telehealth-after-pandemic/

Roche takes on pricey rivals as FDA approves SMA drug

https://pharmaphorum.com/news/roche-takes-on-pricey-rivals-as-fda-approves-sma-drug/

Windrose Consulting Group acquires Parioforma

https://pharmaphorum.com/partner-content/windrose-consulting-group-acquires-parioforma/

Survey shows patients wait six times longer than EU neighbours for new drugs

https://pharmaphorum.com/news/survey-shows-patients-wait-six-times-longer-than-eu-neighbours-for-new-drugs/

The unprecedented challenge of pricing a coronavirus vaccine

https://pharmaphorum.com/views-analysis-market-access/the-unprecedented-challenge-of-pricing-a-coronavirus-vaccine/

Gilead’s remdesivir could be $7.7bn blockbuster – analyst

https://pharmaphorum.com/news/gileads-remdesivir-could-be-7-7bn-blockbuster-analyst/

‘Delusional’ Shkreli refused prison release to fight coronavirus

https://pharmaphorum.com/news/delusional-shkreli-refused-prison-release-to-fight-coronavirus/

Shares in Vertex jump on overnight success of CF triple therapy

https://pharmaphorum.com/news/shares-in-vertex-jump-on-overnight-success-of-cf-triple-therapy/

Daiichi Sankyo: pharma needs to become NHS ‘experts’

https://pharmaphorum.com/views-analysis-market-access/daiichi-sankyo-pharma-needs-to-become-nhs-experts/

Search